---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020524"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:49:38.498444+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical appoints Christina Bailey as VP of Sales ahead of LIBERTY launch

## Summary
- Christina Bailey named VP of Sales; reports to CEO Harel Gadot.
- Bailey brings 20 years med device experience at Boston Scientific, Abbott, Stryker, Intuitive Surgical, Endologix.
- She is a two-time U.S. Olympian and gold medalist (1998 women's hockey).
- Role includes building sales team to support anticipated launch of LIBERTY endovascular robotic system.
- LIBERTY is an investigational device pending FDA 510(k) clearance, not yet for sale in U.S.

## SEC filing metadata
- accession: 0001641172-25-020524
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000164117225020524/0001641172-25-020524-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000164117225020524/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020524
- JSON: https://secwatch.observer/filing/0001641172-25-020524.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020524.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.